Xiao Ying, Liu Xiangqin, Yang Chen, Liu Liping, Guo Xiaoxin, Wang Qi, Gong Bo
1 Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.
2 The Key Laboratory for Human Disease Gene Study of Sichuan Province and Department of Laboratory Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Genet Test Mol Biomarkers. 2019 Jul;23(7):495-500. doi: 10.1089/gtmb.2018.0334. Epub 2019 Jun 4.
Congenital aniridia is a kind of panocular disorder characterized by the absence of the iris in both eyes. () gene mutations have been identified as the most common cause of congenital aniridia. The aim of this study was to reveal the genetic defect in in a Chinese family with congenital aniridia. Twelve individuals from a three-generation Chinese family were recruited. All the family members underwent comprehensive ophthalmologic examinations. The entire coding region of was amplified by polymerase chain reaction, followed by direct Sanger sequencing. Possible structural and functional changes of protein were predicted by bioinformatic analysis using SIFT and Polyohen-2. Among all the 12 members, four were clinically diagnosed with congenital aniridia. A novel heterozygous mutation c.275G>A (p.R92Q) in exon 6 of was identified in all the patients, but not in the unaffected individuals or 1186 healthy subjects. This missense mutation is a G-A transition, converting Arginine (R) to Glutamine (Q) at amino acid 92. The substitution of amino acid in the PAX6 protein changed the local charge density and was predicted to damage the normal protein function. Our study identified a novel mutation of responsible for congenital aniridia in a Chinese family, which may contribute to understanding the molecular basis and clinical diagnosis of congenital aniridia.
先天性无虹膜是一种双眼虹膜缺失的全眼球疾病。()基因突变已被确定为先天性无虹膜最常见的病因。本研究旨在揭示一个中国先天性无虹膜家系中的基因缺陷。招募了一个三代中国家系的12名成员。所有家庭成员均接受了全面的眼科检查。通过聚合酶链反应扩增()的整个编码区,随后进行直接桑格测序。使用SIFT和Polyohen-2通过生物信息学分析预测蛋白质可能的结构和功能变化。在所有12名成员中,4人临床诊断为先天性无虹膜。在所有患者中均鉴定出()外显子6中的一个新的杂合突变c.275G>A(p.R92Q),但未在未受影响的个体或1186名健康受试者中发现。这种错义突变是G-A转换,在氨基酸92处将精氨酸(R)转换为谷氨酰胺(Q)。PAX6蛋白中氨基酸的取代改变了局部电荷密度,并预测会损害正常蛋白质功能。我们的研究在一个中国家系中鉴定出一个导致先天性无虹膜的()新突变,这可能有助于理解先天性无虹膜的分子基础和临床诊断。